- increased bone mineral density / IMPC
- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating calcium level / IMPC
- increased leukocyte cell number / IMPC
- decreased hemoglobin content / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased lean body mass / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating total protein level / IMPC
- decreased total body fat amount / IMPC
- increased red blood cell distribution width / IMPC
- decreased circulating fructosamine level / IMPC
- increased bone mineral content / IMPC
C57BL/6N-Tex261tm1b(EUCOMM)Wtsi/WtsiIeg
Status | Available to order |
EMMA ID | EM:14145 |
International strain name | C57BL/6N-Tex261tm1b(EUCOMM)Wtsi/WtsiIeg |
Alternative name | EPD0520_4_H12 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Tex261tm1b(EUCOMM)Wtsi |
Gene/Transgene symbol | Tex261 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0520_4_H12. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on EUCOMM final vectors. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased red blood cell distribution width / IMPC
- increased bone mineral density / IMPC
- decreased circulating LDL cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating fructosamine level / IMPC
- increased leukocyte cell number / IMPC
- decreased circulating total protein level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating calcium level / IMPC
- decreased total body fat amount / IMPC
- increased circulating alanine transaminase level / IMPC
- increased bone mineral content / IMPC
- increased lean body mass / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased hemoglobin content / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).